Consainsights logo
  • Reports /
  • 23-Valent Pneumococcal Polysaccharide Vaccine Market

23-Valent Pneumococcal Polysaccharide Vaccine Market

23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report – Segmented By Dose Type (SINGLE DOSE VIAL, PRE-FILLED SYRINGE), By Age-group (CHILDREN (2-10 YEARS), ADULTS (10-64 YEARS), GERIATRICS (65 YEARS AND ABOVE)) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.

Table of contents

Executive Summary

23-Valent Pneumococcal Polysaccharide Vaccine Market from Consainsights analyses the 23-Valent Pneumococcal Polysaccharide Vaccine Market Market in the Life Sciences industry over the forecast period to 2027.

Figure 1: 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2019-2027

23-Valent Pneumococcal Polysaccharide Vaccine Market research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

23-Valent Pneumococcal Polysaccharide Vaccine Market segmentation includes Dose Type, Age-group and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Dose Type, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers SINGLE DOSE VIAL, PRE-FILLED SYRINGE.

Figure 2: 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (%), Dose Type 2021

Based on the Age-group, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers CHILDREN (2-10 YEARS), ADULTS (10-64 YEARS), GERIATRICS (65 YEARS AND ABOVE).

Figure 3: 23-Valent Pneumococcal Polysaccharide Vaccine Market Share (%), Age-group 2021

Key companies operating in the market include PFIZER INC., SANOFI S.A., GLAXOSMITHKLINE PLC, MERCK & CO., ASTRAZENECA, BAXTER INTERNATIONAL INC., BEIJING MINHAI BIOTECHNOLOGY, SERUM INSTITUTE OF INDIA, BIOGEN INC., ELI LILLY AND COMPANY and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Market Overview

Definition & Scope

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

By Dose Type

Introduction

By By Dose Type, The 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers SINGLE DOSE VIAL, PRE-FILLED SYRINGE.

Table: 1: 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, By By Dose Type

SINGLE DOSE VIAL

The SINGLE DOSE VIAL segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

PRE-FILLED SYRINGE

The PRE-FILLED SYRINGE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

By Age-group

Introduction

By By Age-group, The 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers CHILDREN (2-10 YEARS), ADULTS (10-64 YEARS), GERIATRICS (65 YEARS AND ABOVE).

Table: 2: 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, By By Age-group

CHILDREN (2-10 YEARS)

The CHILDREN (2-10 YEARS) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ADULTS (10-64 YEARS)

The ADULTS (10-64 YEARS) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

GERIATRICS (65 YEARS AND ABOVE)

The GERIATRICS (65 YEARS AND ABOVE) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

North America

Introduction

Based on the North America, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers US, Canada.

Table 3: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 4: North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

US

Table 5: US 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 6: US 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Canada

Table 7: Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 8: Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Europe

Introduction

Based on the Europe, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Table 9: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 10: Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Germany

Table 11: Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 12: Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

United Kingdom

Table 13: United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 14: United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

France

Table 15: France 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 16: France 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Spain

Table 17: Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 18: Spain 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Russia

Table 19: Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 20: Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Italy

Table 21: Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 22: Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Rest of Europe

Table 23: Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 24: Rest of Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Asia-Pacific

Introduction

Based on the Asia-Pacific, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Table 25: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 26: Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

China

Table 27: China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 28: China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Japan

Table 29: Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 30: Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

India

Table 31: India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 32: India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Southeast Asia

Table 33: Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 34: Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Australia & New Zealand

Table 35: Australia & New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 36: Australia & New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Rest of Asia-Pacific

Table 37: Rest of Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 38: Rest of Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Middle-East & Africa

Introduction

Based on the Middle-East & Africa, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Table 39: Middle-East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 40: Middle-East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Middle East

Table 41: Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 42: Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Africa

Table 43: Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 44: Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Rest of Middle East & Africa

Table 45: Rest of Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 46: Rest of Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Latin America

Introduction

Based on the Latin America, the 23-Valent Pneumococcal Polysaccharide Vaccine Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Table 47: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 48: Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Brazil

Table 49: Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 50: Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Argentina

Table 51: Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 52: Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Mexico

Table 53: Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 54: Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Colombia

Table 55: Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 56: Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Rest of Latin America

Table 57: Rest of Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Dose Type 2019-2027
Table 58: Rest of Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Age-group 2019-2027

Company Analysis

Introduction

Key companies operating in the market include PFIZER INC., SANOFI S.A., GLAXOSMITHKLINE PLC, MERCK & CO., ASTRAZENECA, BAXTER INTERNATIONAL INC., BEIJING MINHAI BIOTECHNOLOGY, SERUM INSTITUTE OF INDIA, BIOGEN INC., ELI LILLY AND COMPANY and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.